Close Menu
Home › Diaceutics, Intel, Lenovo Collaborate on Use of AI for Diagnosis, Treatments

Diaceutics, Intel, Lenovo Collaborate on Use of AI for Diagnosis, Treatments

Mar 07, 2018
|
staff reporter

NEW YORK (360Dx) – Diaceutics this week announced a collaboration with Lenovo and Intel to leverage artificial intelligence to determine if patients can be grouped based on diagnostic test information.

By doing so, the partners believe the data can help identify ways of improving diagnosis, treatment, and outcomes for patients sharing similar characteristics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
30
Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul
31
Featured Webinar

Considerations and Impact of Implementing Targeted NGS in Myeloid Malignancies

Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.

What's Popular?

In Cancer

  1. Cowen, William Blair, JP Morgan Initiate Coverage of Adaptive Biotechnologies

  2. Myriad Genetics Settles Improper Medicare Billing Complaint for $9.1M

  3. Interpace Diagnostics, SelectHealth Sign Coverage Agreement for Thyroid Cancer Tests

  4. Castle Bio Eyes up to $61.3M in Planned IPO

  5. Seer Raises $17.5 M in Series C Financing Round

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.